Thyroid cancer trials in Japan

5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Where

  Kanagawa, Kyoto, Tokyo

  Age

  18 years and over

  People

  554 worldwide

  Run by

  Institut de Recherches Internationales Servier

  See details and how to joinNCT05786924 · EU 2025-523474-16-00
• Phase 1Taking people
  Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

  Where

  Chuo Ku

  Age

  18 years to 100 years

  People

  116 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07006727 · EU 2024-519111-34-00
• Phase 2Not yet taking people in Japan
  Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

  Where

  Tokyo

  Age

  18 years to 99 years

  People

  68 worldwide

  Run by

  National Cancer Centre, Singapore

  See details and how to joinNCT07521670
• Phase 1/2Taking people
  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Where

  Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago

  Age

  12 years and over

  People

  500 worldwide

  Run by

  Turning Point Therapeutics, Inc.

  See details and how to joinNCT03093116 · EU 2024-512606-25-00
• Phase 1Taking people
  A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer

  Where

  Kashiwa

  Age

  18 years and over

  People

  38

  Run by

  Alpha Fusion Inc.

  See details and how to joinNCT07287748